Byron Robinson
Chief Strategy Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Janux Therapeutics, Inc. (JANX)
Proxy statement
Start not stated–2025-09-18
-
Janux Therapeutics, Inc. (JANX)
Proxy statement
Start not stated–2025-09-18
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Janux Therapeutics, Inc. (JANX) | Ph.D., J.D. Former Chief Strategy Officer | $362,728 | $5,063,635 |
| 2024 | Janux Therapeutics, Inc. (JANX) | Ph.D., J.D. Chief Strategy Officer | $485,000 | $3,815,641 |
| 2023 | Janux Therapeutics, Inc. (JANX) | Ph.D., J.D. Chief Strategy Officer | $450,000 | $1,740,990 |
| 2022 | Janux Therapeutics, Inc. (JANX) | Ph.D., J.D. Chief Strategic Officer | $351,945 | $3,367,790 |
| 2021 | Janux Therapeutics, Inc. (JANX) | Ph.D., J.D. Chief Strategy Officer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.